Semitala FC, Kadota JL, Musinguzi A, Nabunje J, et al. Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial. PLoS Med 2021;18:e1003875.
PMID: 34914696